Table 6.
Tumor characteristics as a function of serum GGT levels, within low AFP (<100 IU/mL)
| GGT<30 IU/mL | GGT≥30–100 IU/mL | GGT>100 IU/mL | ||
|---|---|---|---|---|
| Median (min.-max.) | Median (min.-max.) | Median (min.-max.) | p | |
| MTD size | 5 (1–16) | 5 (1–24) | 6 (0.8–20.5) | 0.051 |
| AFP | 4.5 (1.2–98.1)a | 10 (0.5–99)b | 9.1 (0.5–95.9)b | 0.010 |
| % | % | % | p | |
| Tumor # ≤ 2 | 78.4 | 68.1 | 51.5 | 0.005 |
| Tumor # > 2 | 21.6 | 31.9 | 48.5 | |
| PVT (−) | 83.3 | 83.8 | 67.0 | 0.009 |
| PVT (+) | 16.7 | 16.2 | 33.0 |
Superscript
groups are not different from each other, but are significantly different to superscript
groups. Abbreviations: GGT: Gamma glutamyl transpeptidase: (IU/mL); MTD: Maximum tumor diameter; AFP: Alpha-fetoprotein; PVT: Macroscopic portal vein thrombosis